Four criteria for evaluating biomarkers of immunosuppression in sepsis
10.3760/cma.j.cn114452-20230519-00249
- VernacularTitle:评价脓毒症免疫抑制生物标志物的4个标准
- Author:
Fei PEI
1
;
Jianfeng WU
Author Information
1. 中山大学附属第一医院重症医学科 广东省重症医学临床研究中心，广州 510080
- Keywords:
Sepsis;
Immune monitoring;
Immunosuppression;
mHLA-DR;
Lymphocyte counts
- From:
Chinese Journal of Laboratory Medicine
2023;46(10):992-996
- CountryChina
- Language:Chinese
-
Abstract:
Immunosuppression is a key element of poor prognosis in patients with sepsis. The immune status assessment is a prerequisite for identifying immunosuppressed patients and clarifying the timing of immunotherapy. Exploring biomarkers for immune status assessment in sepsis has become a current hot spot. However, the availability of a large number of biomarkers in recent years has presented clinicians with a selection problem. There is four criteria for ideal biomarkers of sepsis immunosuppression for the screening of potential biomarkers of sepsis immunosuppression.
